These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37577806)

  • 1. Mixed and non-competitive enzyme inhibition: underlying mechanisms and mechanistic irrelevance of the formal two-site model.
    Pesaresi A
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2245168. PubMed ID: 37577806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrate-Induced Facilitated Dissociation of the Competitive Inhibitor from the Active Site of O-Acetyl Serine Sulfhydrylase Reveals a Competitive-Allostery Mechanism.
    Singh AK; Ekka MK; Kaushik A; Pandya V; Singh RP; Banerjee S; Mittal M; Singh V; Kumaran S
    Biochemistry; 2017 Sep; 56(37):5011-5025. PubMed ID: 28805060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statistical Mechanics of Allosteric Enzymes.
    Einav T; Mazutis L; Phillips R
    J Phys Chem B; 2016 Jul; 120(26):6021-37. PubMed ID: 27070509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-competitive inhibition by active site binders.
    Blat Y
    Chem Biol Drug Des; 2010 Jun; 75(6):535-40. PubMed ID: 20374252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic analysis of allosteric and non-allosteric effects arising from nanobody binding to two epitopes of the dihydrofolate reductase of Escherichia coli.
    Oyen D; Wechselberger R; Srinivasan V; Steyaert J; Barlow JN
    Biochim Biophys Acta; 2013 Oct; 1834(10):2147-57. PubMed ID: 23911607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective Covalent Inhibition of "Allosteric Cys121" Distort the Binding of PTP1B Enzyme: A Novel Therapeutic Approach for Cancer Treatment.
    Khan S; Bjij I; Soliman MES
    Cell Biochem Biophys; 2019 Sep; 77(3):203-211. PubMed ID: 31446553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric inhibition of the neuropeptidase neurolysin.
    Hines CS; Ray K; Schmidt JJ; Xiong F; Feenstra RW; Pras-Raves M; de Moes JP; Lange JH; Melikishvili M; Fried MG; Mortenson P; Charlton M; Patel Y; Courtney SM; Kruse CG; Rodgers DW
    J Biol Chem; 2014 Dec; 289(51):35605-19. PubMed ID: 25378390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uncoupling of an ammonia channel as a mechanism of allosteric inhibition in anthranilate synthase of Serratia marcescens: dynamic and graph theoretical analysis.
    Srivastava A; Sinha S
    Mol Biosyst; 2016 Dec; 13(1):142-155. PubMed ID: 27833951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition patterns of a model complex mimicking the reductive half-reaction of sulphite oxidase.
    Chaudhury PK; Das SK; Sarkar S
    Biochem J; 1996 Nov; 319 ( Pt 3)(Pt 3):953-9. PubMed ID: 8921005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic differences in inhibition of ubiquinol cytochrome c reductase by the proximal Qo-site inhibitors famoxadone and methoxyacrylate stilbene.
    Pember SO; Fleck LC; Moberg WK; Walker MP
    Arch Biochem Biophys; 2005 Mar; 435(2):280-90. PubMed ID: 15708371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of novel allosteric effectors based on the predicted allosteric sites for Escherichia coli D-3-phosphoglycerate dehydrogenase.
    Wang Q; Qi Y; Yin N; Lai L
    PLoS One; 2014; 9(4):e94829. PubMed ID: 24733054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two sites of action for PLD2 inhibitors: The enzyme catalytic center and an allosteric, phosphoinositide biding pocket.
    Ganesan R; Mahankali M; Alter G; Gomez-Cambronero J
    Biochim Biophys Acta; 2015 Mar; 1851(3):261-72. PubMed ID: 25532944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absolute configuration and protein tyrosine phosphatase 1B inhibitory activity of xanthoepocin, a dimeric naphtopyrone from Penicillium sp. IQ-429.
    Martínez-Aldino IY; Villaseca-Murillo M; Morales-Jiménez J; Rivera-Chávez J
    Bioorg Chem; 2021 Oct; 115():105166. PubMed ID: 34384957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competition and allostery govern substrate selectivity of cyclooxygenase-2.
    Mitchener MM; Hermanson DJ; Shockley EM; Brown HA; Lindsley CW; Reese J; Rouzer CA; Lopez CF; Marnett LJ
    Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12366-71. PubMed ID: 26392530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential behavior of the sub-sites of cytochrome 450 active site in binding of substrates, and products (implications for coupling/uncoupling).
    Narasimhulu S
    Biochim Biophys Acta; 2007 Mar; 1770(3):360-75. PubMed ID: 17134838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic evaluation of substrate inhibition kinetics observed from aldehyde oxidase-catalyzed reactions.
    Wang SW; Abdul-Hadi K; Cohen L; Xia CQ
    Drug Metab Lett; 2013 Mar; 7(1):2-14. PubMed ID: 24151826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Citral Inhibition of Human Salivary Aldehyde Dehydrogenase.
    Laskar AA; Khan MA; Ahmad S; Hashmi A; Younus H
    Cell Biochem Biophys; 2020 Mar; 78(1):31-42. PubMed ID: 31732914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in the allosteric inhibition of glycogen phosphorylase.
    Loughlin WA
    Mini Rev Med Chem; 2010 Oct; 10(12):1139-55. PubMed ID: 20716052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A geometry-based generic predictor for catalytic and allosteric sites.
    Mitternacht S; Berezovsky IN
    Protein Eng Des Sel; 2011 Apr; 24(4):405-9. PubMed ID: 21159618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico investigations on the binding efficacy and allosteric mechanism of six different natural product compounds towards PTP1B inhibition through docking and molecular dynamics simulations.
    SarathKumar B; Lakshmi BS
    J Mol Model; 2019 Aug; 25(9):272. PubMed ID: 31451955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.